HUMACYTE INC (HUMA) Stock Balance Sheet
NASDAQ:HUMA - Nasdaq - US44486Q1031 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 217.50M | 1.09M | |||
| Cash Equivalents | 20.57M | 80.45M | 149.80M | 217.50M | 39.90M | |||
| Marketable Securities | N/A | 0.00 | 2.10M | 8.00M | N/A | |||
| Receivables | N/A | 0.00 | 0.00 | 200.00K | 100.00K | |||
| Other Current Assets | 2.43M | 2.83M | 2.30M | 3.70M | 1.40M | |||
| Total Current Assets | 23.00M | 83.28M | 154.20M | 229.30M | 41.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 40.26M | 44.70M | 50.10M | 57.20M | 65.20M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 100.02M | |||
| Other Non-Current Assets | 51.50M | 241.00K | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 91.76M | 44.95M | 50.10M | 57.20M | 65.30M | |||
| TOTAL ASSETS | 114.76M | 128.22M | 204.30M | 286.50M | 106.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.83M | 2.56M | 10.80M | 2.00M | 4.20M | |||
| Accrued Expenses | 11.21M | 9.39M | 7.20M | 6.80M | 4.60M | |||
| Accounts Payable | 6.90M | 6.49M | 1.60M | 2.10M | 2.30M | |||
| Other Current Liabilities | N/A | 2.61M | 0.00 | 200.00K | 100.00K | |||
| Total Current Liabilities | 20.94M | 18.44M | 19.60M | 11.10M | 11.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 14.38M | 16.29M | 39.20M | 48.50M | 23.90M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 100.00K | |||
| Other Non-Current Liabilities | 143.16M | 79.94M | 28.60M | 104.80M | 700.00K | |||
| Total Non-Current Liabilities | 157.54M | 96.23M | 67.80M | 153.30M | 24.80M | |||
| TOTAL LIABILITIES | 178.49M | 114.68M | 87.40M | 164.40M | 36.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -665.08M | -537.31M | -426.50M | -414.60M | -388.10M | |||
| Additional Paid In Capital | 601.34M | 550.85M | 543.50M | 536.70M | 37.80M | |||
| Common Shares | 12.00K | 10.00K | 0.00 | 0.00 | 421.00M | |||
| Shares Outstanding | 119.84M | 103.67M | 103.20M | 103.00M | 103.00M | |||
| Tangible Book Value per Share | -0.53 | 0.13 | 1.13 | 1.19 | -3.40 | |||
| Total Shareholders' Equity | -63.72M | 13.55M | 116.90M | 122.20M | 70.70M | |||
| TOTAL LIABILITIES AND EQUITY | 114.76M | 128.22M | 204.30M | 286.50M | 106.70M | |||
| Statistics | ||||||||
| Debt/Equity | -0.23 | 1.20 | 0.34 | 0.40 | 0.34 | |||
| Current Ratio | 1.10 | 4.52 | 7.87 | 20.66 | 3.70 | |||
| Return On Assets (ROA) | -133.20% | -86.39% | -5.86% | -9.24% | -62.34% | |||
| Return On Equity (ROE) | N/A | -817.78% | -10.24% | -21.67% | -94.09% | |||
All data in USD , ROIC based on taxRate of 0.21